PAR:LNA
LNA Santé S.A. · PAR · Healthcare · EUR · FY for 2025
Figures on this page computed 2026-11-08 00:57 UTC
Last close
n/aEUR
Market data
We are not showing closes for this listing. A line drawn through points we do not hold would look exactly like a listing that did not move.
11.2xP/E
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- EUR
- computed
- Computed from the filing for 2025
3.4%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
2.6%Net margin
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
6.5%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
2.75Debt/equity
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
2.5%Dividend yield
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- EUR
- computed
Safety is the furthest below its sector's middle: 0.21 against 0.57 on the market's range.
Five bars, one line
lens 7 of 9Each against its own average
4 of 5 readExcept where said otherwise: Computed from the filing for 2025
- Sales1.41x
Its own average over 10 years, 647.5M.
- Profit1.12x
Its own average over 10 years, 21.5M.
- Free cash flow0.81x
Its own average over 10 years, 73.0M.
- Debt1.22x
Its own average over 10 years, 742.3M.
- Pricen/a
Its own average over 0 years. Market data
Sales is furthest from its own average, at 1.41 times.
The filed years, as a table
10Each line is 100 at 2016-12-31, the first year we hold.
| Filed year | Sales | Profit | Shares in issue |
|---|---|---|---|
| 2016-12-31 | 100.0 | 100.0 | 100.0 |
| 2017-12-31 | 102.5 | 112.0 | 107.4 |
| 2018-12-31 | 113.4 | 99.6 | 107.2 |
| 2019-12-31 | 111.1 | 96.3 | 107.0 |
| 2020-12-31 | 120.8 | 36.1 | 106.2 |
| 2021-12-31 | 145.2 | 108.7 | 106.4 |
| 2022-12-31 | 153.3 | 119.4 | 114.8 |
| 2023-12-31 | 155.0 | 108.3 | 113.3 |
| 2024-12-31 | 169.8 | 100.9 | 118.7 |
| 2025-12-31 | 192.1 | 111.7 | 113.7 |
How sales was got
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- EUR
How profit was got
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- EUR
How shares in issue was got
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- EUR
Figures behind the shape
Growth
9.7%faster is higher, placed against 4,950 companies as of 2026-11-07
Five-year revenue growth rate9.7%
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- EUR
- computed
Five-year EPS growth rate23.7%
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- EUR
- computed
One-year change in net income10.7%
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- EUR
- computed
Returns on capital
3.4%higher is higher, placed against 5,089 companies as of 2026-11-07
Return on invested capital3.4%
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
Return on equity7.3%
Net Income / Shareholders' Equity x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
Return on assets1.5%
Net Income / Total Assets x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
Margins
14.5%wider is higher, placed against 3,412 companies as of 2026-11-07
Gross margin14.5%
Gross Profit / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
Operating margin6.6%
Operating Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
Net margin2.6%
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
Free cash flow margin6.5%
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
Price
11.2xcheaper is higher, placed against 4,362 companies as of 2026-11-07
Price to earnings11.2x
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- EUR
- computed
- Computed from the filing for 2025
Price to book0.8x
Price / Book Value per Share, where BVPS = Shareholders' Equity / Diluted Shares
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- EUR
- computed
- Computed from the filing for 2025
- computed
- Computed from the filing for 2025
EV to EBITDA7.6x
Enterprise Value / EBITDA, where EV = Market Cap + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- EUR
- computed
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
Price to sales ratio0.3x
Market Cap / Revenue, where Market Cap = Price x Diluted Shares
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- EUR
- computed
- Computed from the filing for 2025
- Computed from the filing for 2025
Safety
2.75safer is higher, placed against 3,227 companies as of 2026-11-07
Debt to equity2.75
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
Current ratio0.91
Current Assets / Current Liabilities
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
Interest coverage2.0x
Operating Income / Interest Expense
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
Altman Z-Score0.82
1.2 x A + 1.4 x B + 3.3 x C + 0.6 x D + 1.0 x E (A=WC/TA, B=RE/TA, C=EBIT/TA, D=MktCap/TL, E=Rev/TA)
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
What it pays out
2.5%more, and better covered, is higher, placed against 1,091 companies as of 2026-11-07
Dividend yield2.5%
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- EUR
- computed
Payout ratio27.6%
Common Dividends Paid / Net Income x 100, both from the latest filed fiscal year
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
Dividend cover ratio8.9x
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- EUR
- computed
Share a finding
A link to the finding, not to you: it carries nothing about your account.